"Rather than working to lower insulin and other Type 2 diabetes medication prices, major [pharmacy benefit managers] and manufacturers use their dominant market positions to drastically increase the price of these necessary, life-saving medications, generating billions of dollars in illicit profits," co-lead counsel for the plaintiff claimed in a joint statement.
April 23, 2024 at 03:31 PM
4 minute read
Litigation Reporter
Multiple drug manufacturers and pharmacy benefit managers, CVS Health, Eli Lilly, Novo Nordisk and others face civil RICO claims from the International Union of Operating Engineers Local No. 478 Health Fund.
The plaintiff is a Taft Hartley fund, which provides union members with health benefits.
Presented by BigVoodoo
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Credit: Towfiqu Barbhuiya/Adobe Stock
